Literature DB >> 9890583

Treating substance abuse among patients with schizophrenia.

A S Bellack1, C C DiClemente.   

Abstract

Although substance abuse has reached epidemic proportions among people with schizophrenia, relatively little is known about the critical elements of effective treatment of substance abuse in this population. The authors discuss common assumptions about treatment of substance abuse and review the features of the transtheoretical model of change, which is based on the view that behavior change is a longitudinal process consisting of several stages. In this model, substance abusers must first be persuaded to reduce substance use and then be engaged in treatment before they can be taught the skills necessary to become and remain abstinent. The authors suggest an adaptation of the model that attempts to minimize the impact of the cognitive and motivational deficits associated with schizophrenia. The six-month treatment protocol contains four modules focusing on social skills and problem solving, education about the causes and dangers of substance use, motivational interviewing and goal setting for decreased substance use, and training in behavioral skills for relapse prevention. In the 90-minute, twice weekly sessions, behavioral rehearsal is emphasized, and complex social repertoires, such as refusing substances, are divided into smaller behavioral elements.

Entities:  

Mesh:

Year:  1999        PMID: 9890583     DOI: 10.1176/ps.50.1.75

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  27 in total

Review 1.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 2.  Psychosocial treatments for schizophrenia.

Authors:  A S Bellack; S A Brown
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

3.  Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures.

Authors:  K B Carey; S A Maisto; M P Carey; D M Purnine
Journal:  J Stud Alcohol       Date:  2001-01

Review 4.  Tactics and technologies to manage nonadherence in patients with schizophrenia.

Authors:  William M Glazer; Mathew J Byerly
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

5.  [State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial].

Authors:  A Bechdolf; B Pohlmann; J Güttgemanns; C Geyer; K Lindner; C Ferber; E Gouzoulis-Mayfrank
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

6.  Feasibility, Acceptability, and Preliminary Efficacy of a Live-Chat Social Media Intervention to Reduce HIV Risk Among Young Men Who Have Sex With Men.

Authors:  Corina Lelutiu-Weinberger; John E Pachankis; Kristi E Gamarel; Anthony Surace; Sarit A Golub; Jeffrey T Parsons
Journal:  AIDS Behav       Date:  2015-07

7.  Motivational profiles of clients seeking methadone maintenance therapy in China.

Authors:  Li Li; Yingying Ding; Wenhong Lai; Chunqing Lin; Wei Luo
Journal:  Drug Alcohol Depend       Date:  2011-05-14       Impact factor: 4.492

Review 8.  Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Authors:  Douglas M Ziedonis; David Smelson; Richard N Rosenthal; Steven L Batki; Alan I Green; Renata J Henry; Ivan Montoya; Joseph Parks; Roger D Weiss
Journal:  J Psychiatr Pract       Date:  2005-09       Impact factor: 1.325

9.  Predictors of smoking cessation group treatment engagement among veterans with serious mental illness.

Authors:  Letitia E Travaglini; Lan Li; Clayton H Brown; Melanie E Bennett
Journal:  Addict Behav       Date:  2017-07-10       Impact factor: 3.913

10.  A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders.

Authors:  David A Graeber; Theresa B Moyers; Gayle Griffith; Eliseo Guajardo; Scott Tonigan
Journal:  Community Ment Health J       Date:  2003-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.